Marksans Pharma Ltd (NSE:MARKSANS)
₹ 168.45 -0.6 (-0.35%) Market Cap: 76.34 Bil Enterprise Value: 70.73 Bil PE Ratio: 23.83 PB Ratio: 4.01 GF Score: 83/100

Q2 2023 Marksans Pharma Ltd Earnings Call Transcript

Nov 16, 2022 / 12:30PM GMT
Release Date Price: ₹54.15 (+1.59%)
Operator

Good evening, ladies and gentlemen. I'm Krithika Moderator for Marksans Pharma Q2 FY23 earnings conference call, hosted by DAM Capital Advisors Limited. (Operator Instructions) Please note this conference is recorded. I would now like to hand over the floor to Mr. Nitin Agarwal from DAM Capital. Thank you and over to you sir.

Nitin Agarwal
DAM Capital Advisors Limited - Analyst

Thanks Krithika. Hi, good evening, everyone, and a very warm welcome to Marksans Pharma's Q2 FY23 &H1 earnings call, hosted by DAM Capital Advisors. On the call today, we have representing Marksans management Mr. Mark Saldanha, Founder, Chairman and Managing Director; and Mr. Jitendra Sharma, Chief [Financial] Officer. I will hand over the call to Mark, to make the opening comments and we will open it for questions.

Mark Saldanha
Marksans Pharma Ltd. - MD & CEO

Yeah, Hi Nitin, thank you, and welcome and thank everyone for joining us on our Q2 FY23 and H1 FY23 earnings. I'm pleased to announce that we have had a strong financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot